Patient-Surgeon Sex Mismatch Doesn’t Drive Disparities in Cardiac Surgery

Why It Matters

The findings redirect attention from surgeon gender to systemic factors, indicating that improving women’s cardiac surgery outcomes will require broader team and structural changes rather than matching patient‑surgeon sex.

Key Takeaways

• Sex concordance did not change 30‑day mortality or morbidity
• Five‑year outcomes similarly unaffected by surgeon‑patient gender mismatch
• Team‑based, standardized cardiac surgery may dilute individual surgeon impact
• Female surgeon representation remains low, limiting subgroup analysis
• Future databases must capture provider details to explore disparities

Pulse Analysis

Women consistently experience higher complication rates after cardiac surgery, prompting researchers to explore whether the gender of the operating surgeon plays a role. Prior studies in general surgery hinted that patient‑surgeon sex discordance could influence outcomes, leading to the hypothesis that a similar effect might exist in the high‑risk arena of cardiac procedures. By leveraging a national Medicare cohort spanning 2010‑2021, the Cornell team examined over 223,000 bypass, valve and aortic cases to test this theory, stratifying results by both patient and surgeon sex.

The analysis revealed no statistically significant differences in 30‑day mortality, composite morbidity, or five‑year survival based on whether the surgeon’s gender matched the patient’s. Even when minor variations appeared—such as slightly lower five‑year event rates for male patients treated by female surgeons—the multivariable models showed an odds ratio of 1.00, indicating no independent effect. Researchers attribute this neutrality to cardiac surgery’s reliance on multidisciplinary teams, including anesthesiologists, cardiologists and perfusionists, as well as the field’s rigorous, standardized protocols that reduce individual operator variability.

While the study closes one hypothesis, it opens another: the persistent outcome gap for women likely stems from broader systemic issues rather than surgeon gender alone. The authors call for richer data collection on provider characteristics and advocate for increasing the pipeline of female cardiac surgeons. As upcoming trials like ROMA‑Women begin to capture detailed provider information, the specialty may finally pinpoint modifiable factors—whether they be peri‑operative care pathways, referral patterns, or implicit biases—that can close the gender disparity in cardiac surgery outcomes.